London, 21 May 2026 – G Square Healthcare Private Equity LLP (“G Square”) has successfully closed the sale of portfolio company Medadom to Verdane, BPI, and the founders, marking the successful conclusion of a landmark investment in one of France’s most innovative digital health businesses. The transaction supports Medadom’s next phase of growth as a leading telehealth platform, expanding access to care for patients across France.
G Square invested in Medadom in 2020, partnering with the Company’s management team to accelerate its growth through targeted investment in technology, talent and operations. Over the investment period, Medadom scaled its organic revenue which is a testament to the strength of the underlying platform, the quality of the team and the structural tailwinds driving digital health adoption across Europe.
The transaction reflects G Square’s strategy of identifying high-quality, founder-led healthcare businesses at an inflection point and working alongside them to build market-defining companies.
Renaud Dessertenne, Partner at G Square, said: “Medadom is a remarkable business that has transformed how millions of patients across France access primary care. We are proud of what the team has achieved over the past five years and confident that, with Verdane’s and BPIs support, the Company will continue to go from strength to strength.”
G Square wishes Verdane, BPI, and the founders every success in the next chapter.
Contacts
Renaud Dessertenne
Partner
Email: contact@gsquarecapital.com
Phone: +44 2037570160